Click here to access The GLP-1 RA's Role in the Management of Diabetes: Tools for the Primary Care Professional presentation slides.
AACE Certificate: Fundamentals of Diabetes Technology
CME : 6 | Nursing : 6
Start: 5/13/2024 | Expiration 5/13/2026
This introductory and comprehensive online certificate program will explore diabetes technology, including continuous glucose monitoring (CGM), remote glucose monitoring, insulin pumps, and connected insulin pens.
$295 | Informed Members - $235 | Engaged Members - $175
AACE Certificate: Inpatient Diabetes
CME : 7 | Nursing : 7
Starts: 1/28/2025 | Expires: 1/28/2027
The Inpatient Diabetes Certificate is a comprehensive program that prepares healthcare professionals to effectively manage diabetes and hyperglycemia in hospitalized patients.
$295 | Informed Members - $235 | Engaged Members - $175
GLP-1 RA’s Role in the Management of Diabetes: Tools for the Primary Care Professional
CME : 1.5 | ABIM MOC : 1.5
Starts 10/31/2024 | Expires 10/31/2025
This program aims to equip primary care professionals with the skills to manage type 2 diabetes more effectively, particularly those who may be hesitant to prescribe glucagon-like peptide-1 receptor agonists (GLP-1 RAs).
Clinical Conversations in Diabetes Technology: Resources and Acceptance
CME : 1.25 | Nursing : 1.25
Starts 5/31/2024 | Expires 5/31/2025
This initiative is designed to help primary care clinicians establish practice-level strategies for enhancing patient-centered care of diabetes with diabetes technology. The educational strategies learned through this program will address the opportunities for implementation in practices of various sizes and resources.
MASLD and MASH: Early Identification to Decrease Associated Complications
CME : 2 | 2 : ABIM-MOC
Starts: 8/19/2024 | Expires: 8/19/2025
Access our FREE online course designed to equip healthcare professionals with the latest knowledge and tools to effectively identify and manage patients at risk for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Metabolic Dysfunction-Associated Steatohepatitis (MASH).
AACE Advocacy Training Program
On-demand access is now available for our free AACE Advocacy Training Program. This program was designed to empower endocrinologists, endocrine care team members, industry professionals, and patient advocates with the knowledge, strategies, and tools to become an effective advocate for endocrine issues such as improved access to endocrine care.
This algorithm provides concise visual guidance in the form of algorithms to assist with clinical decision-making for the management of persons with type 2 diabetes mellitus and related comorbidities.
AvoMD, a software platform that brings clinical evidence into the workflow to help clinicians streamline decisions and save time, has partnered with AACE to integrate clinical guidance documents into the AvoMD platform.
This updated guideline provides recommendations for the care and management of people with or at risk for diabetes mellitus at every stage, including prevention, diagnosis, and treatment.
View a step-by-step guide to getting started with CGM devices in your practice.
Read More
Compare and contrast FDA-approved CGM systems to find what is right for each individual patient and your practice.
Read More
An action plan is an important part of the diabetes care plan and can be implemented after the initial review of the AGP Report. Here is an example action plan for you to use in your own practice.
Read More
The more your patients know about diabetes technology, the better equipped they will be to manage their diabetes and reduce their risk of complications. Provide them with a reliable, informative resource by pointing them to the AACE Patient Journey of Diabetes Technology. The Journey is derived from our clinical guidance documents and reviewed by the DiabetesSisters, a leading patient advocacy organization.
Read More
Early detection and monitoring of Type 1 Diabetes (T1D) are crucial for improving patient outcomes and quality of life. Join clinical experts Lubaina S. Presswala, DO, FACOI, FACE; Jeff Unger, MD, FAAFP, FACE, DACD; and Javier Morales, MD, FACP, FACE, as they discuss the growing prevalence of T1D, the importance of autoantibody screening, the different stages of T1D, screening guidelines, patient counseling, and how early intervention can help delay progression and reduce complications. Support for this podcast is provided by Sanofi.
Learn More